Schizophrenia Research
Volume 89, Issue 1 , Pages 129-139 , January 2007

Remission in early psychosis: Rates, predictors, and clinical and functional outcome correlates

  • Robin Emsley

      Affiliations

    • University of Stellenbosch, Tygerberg, Cape Town, South Africa
    • ,
  • Jonathan Rabinowitz

      Affiliations

    • Bar Ilan University, Israel
    • Corresponding Author InformationCorresponding author. Tel.: +972 9 748 3679; fax: +972 9 740 1318.
    • ,
  • Rossella Medori

      Affiliations

    • Janssen-Cilag EMEA, Beerse, Belgium
    • ,
  • Early Psychosis Global Working Group

Received 23 June 2006 ,Revised 12 September 2006 ,Accepted 12 September 2006.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

☆ The randomized controlled drug trial presented in this paper was funded by Johnson and Johnson Pharmaceutical Research and Development. The study included the following investigators and locations: Australia - P. McGorry (Melbourne); T. Lambert (Bentley); J. Kulkarni (Dandenong); Austria - W. Fleischhacker (Innsbruck); Canada - D. Addington (Calgary); L. Kopala (Halifax); R. Williams (Calgary); G. Chouinard (Montreal); A. Labelle (Ottawa); A. Malla (London); S. Purdon (Edmonton); M. Saxena (Hamilton); V. Nair (Montreal); R. Matte (Sherbrooke); S. Johnson (St. John's); L. Beauclair (Montreal); Finland - K. Lehtinen (Tampere); France - E.R. Lombertie (Limoges); J-A. Meynard (La Rochelle); Germany - H. Freyberger (Stralsund); H-J. Möller (Munich); Israel - A. Caspi; M. Davidson (Ramat-Gan); A. Elitzur (Bat-Yam); M. Kotler (Beer Sheva); I. Treves (Hod-Hasharon); A. Weizman (Petach-Tikva); Netherlands - P. Dries (Portugal); New Zealand - D. Codyre (Auckland); South Africa - R. Emsley (Cape Town); C. Gagiano (Bloemfontein); United Kingdom - M. Reveley (Leicester); T. Sharma (London); United States of America - J. Csernansky (St. Louis); L. DeLisi (Stony Brook); J. Lauriello (Albuquerque); T. Manschreck (Fall River); J. Pahl (Oklahoma City); N. Schooler, M. Keshavan (Pittsburgh); S. Schulz (Cleveland); S. Targum (Philadelphia); S. Risch (Charleston).

PII: S0920-9964(06)00405-1

doi: 10.1016/j.schres.2006.09.013

Schizophrenia Research
Volume 89, Issue 1 , Pages 129-139 , January 2007

Article Tools

* Image Usage & Resolution